Philadelphia, Pennsylvania 19104


Purpose:

To identify outcome measures for cancer control in Head and Neck cancer patient populations at the University of Pennsylvania (HUP, PAH, Presby) by administering various functional outcome surveys and questionnaires about their reconstructive surgery. We hope to ultimately develop a QOL indicator that will reflect the impact of reconstructive surgery on patient's quality of life, and help with therapeutic interventions and explanation of expectations prior to surgery.


Criteria:

Inclusion Criteria: - Subjects who have consented to Otorhinolaryngology Research Registry and are undergoing free flap surgery. Exclusion Criteria: - No children, pregnant women, or prisoners will be consented.


NCT ID:

NCT02530112


Primary Contact:

Principal Investigator
Steven Cannady, MD
Abramson Cancer Center of the University of Pennsylvania

Steven Cannady, MD
Phone: 855-216-0098
Email: PennCancerTrials@emergingmed.com


Backup Contact:

N/A


Location Contact:

Philadelphia, Pennsylvania 19104
United States

Steven Cannady, MD
Phone: 855-216-0098
Email: PennCancerTrials@emergingmed.com

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 23, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.